prevymis
Generic: letermovir
Labeler: merck sharp & dohme llcDrug Facts
Product Profile
Brand Name
prevymis
Generic Name
letermovir
Labeler
merck sharp & dohme llc
Dosage Form
PELLET
Routes
Active Ingredients
letermovir 120 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0006-5085
Product ID
0006-5085_282d792e-e2f2-4744-8526-4d18427c55cb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA219104
Listing Expiration
2027-12-31
Marketing Start
2024-08-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00065085
Hyphenated Format
0006-5085
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
prevymis (source: ndc)
Generic Name
letermovir (source: ndc)
Application Number
NDA219104 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 120 mg/1
Packaging
- 30 PACKET in 1 CARTON (0006-5085-01) / 48 PELLET in 1 PACKET
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "282d792e-e2f2-4744-8526-4d18427c55cb", "openfda": {"nui": ["N0000193800", "N0000193801", "N0000190114", "N0000190107", "N0000190108", "N0000187062", "N0000185507", "N0000185607"], "unii": ["1H09Y5WO1F"], "rxcui": ["1988652", "1988657", "1988660", "1988661", "1988666", "1988671", "1988673", "1988675", "2693185", "2693189", "2693191", "2693193"], "spl_set_id": ["1b49df80-be4f-47e0-a0b7-123f3e69395b"], "pharm_class_epc": ["Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]"], "pharm_class_moa": ["DNA Terminase Complex Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (0006-5085-01) / 48 PELLET in 1 PACKET", "package_ndc": "0006-5085-01", "marketing_start_date": "20240830"}], "brand_name": "PREVYMIS", "product_id": "0006-5085_282d792e-e2f2-4744-8526-4d18427c55cb", "dosage_form": "PELLET", "pharm_class": ["Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]", "DNA Terminase Complex Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]"], "product_ndc": "0006-5085", "generic_name": "LETERMOVIR", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PREVYMIS", "active_ingredients": [{"name": "LETERMOVIR", "strength": "120 mg/1"}], "application_number": "NDA219104", "marketing_category": "NDA", "marketing_start_date": "20240830", "listing_expiration_date": "20271231"}